ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market
Holding AVBP?
Track your performance easily

ArriVent BioPharma, Inc. (AVBP) Balance Sheet

20 Followers

ArriVent BioPharma, Inc. Balance Sheet

ArriVent BioPharma, Inc.'s total assets for Q2 2024 were $308.86M, an increase of 69.71% from the previous quarter. AVBP total liabilities were $12.20M for the fiscal quarter, a 20.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22
Total Assets
$ 182.83M
Total Liabilities
$ 8.37M
Total Equity Gross Minority
$ 174.46M
Total Capitalization
$ 174.46M
Preferred Stock Equity
-
Capital Lease Obligations
-
Currency in USD

ArriVent BioPharma, Inc. Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis